Arkolith/Insider Trading/IDRA/Form 4

Taylor John Clayton

Chief Executive Officer, DirectorIDERA PHARMACEUTICALS, INC. (IDRA) · full profile →Form 4 · filed Sep 30, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 28, 2022Grant(A)2.2M——2.2M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 28, 2022Grant(A)23K——23K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-22-104797) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML